228 related articles for article (PubMed ID: 1316078)
1. A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis.
Mouton Y; Ajana F; Chidiac C; Capron MH; Home P; Masquelier AM
Am J Med; 1992 Apr; 92(4A):87S-90S. PubMed ID: 1316078
[TBL] [Abstract][Full Text] [Related]
2. Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
Guibert J; Capron MH
J Int Med Res; 1992 Nov; 20(6):467-74. PubMed ID: 1337525
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: results from a multicenter study.
Andrade-Villanueva J; Flores-Gaxiola A; Lopez-Guillen P; Aguirre-Avalos G; Morfin-Otero R; Rodriguez-Noriega E
Am J Med; 1992 Apr; 92(4A):71S-74S. PubMed ID: 1316074
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
[TBL] [Abstract][Full Text] [Related]
5. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
[TBL] [Abstract][Full Text] [Related]
7. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection.
Cox CE; Serfer HS; Mena HR; Briefer C; Childs SJ; Gordon SF; Zoller JS
Clin Ther; 1992; 14(3):446-57. PubMed ID: 1638586
[TBL] [Abstract][Full Text] [Related]
8. Lomefloxacin versus trimethoprim/sulfamethoxazole in the treatment of adults with acute bacterial diarrhea.
Seto WH; Lau FL; Gotuzzo EH; Carillo C
Int J Antimicrob Agents; 1992 Dec; 2(1):61-6. PubMed ID: 18611521
[TBL] [Abstract][Full Text] [Related]
9. A cost-effectiveness analysis of treatment strategies for acute uncomplicated pyelonephritis in women.
Yen ZS; Davis MA; Chen SC; Chen WJ
Acad Emerg Med; 2003 Apr; 10(4):309-14. PubMed ID: 12670842
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
Gomolin IH; Siami PF; Reuning-Scherer J; Haverstock DC; Heyd A;
J Am Geriatr Soc; 2001 Dec; 49(12):1606-13. PubMed ID: 11843992
[TBL] [Abstract][Full Text] [Related]
11. Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection.
Stuck AK; Täuber MG; Schabel M; Lehmann T; Suter H; Mühlemann K
Antimicrob Agents Chemother; 2012 Mar; 56(3):1359-63. PubMed ID: 22232276
[TBL] [Abstract][Full Text] [Related]
12. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
Iravani A
Am J Med; 1992 Apr; 92(4A):75S-81S. PubMed ID: 1316075
[TBL] [Abstract][Full Text] [Related]
15. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
Neringer R; Forsgren A; Hansson C; Ode B
Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis.
Richard GA; Klimberg IN; Fowler CL; Callery-D'Amico S; Kim SS
Urology; 1998 Jul; 52(1):51-5. PubMed ID: 9671870
[TBL] [Abstract][Full Text] [Related]
17. Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.
Sutton JD; Stevens VW; Chang NN; Khader K; Timbrook TT; Spivak ES
JAMA Netw Open; 2020 Oct; 3(10):e2020166. PubMed ID: 33030555
[TBL] [Abstract][Full Text] [Related]
18. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women.
Garrison J; Hooton TM
Expert Opin Pharmacother; 2001 Aug; 2(8):1227-37. PubMed ID: 11584990
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections.
Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ
Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
